{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:37:53Z","timestamp":1777451873517,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973332"],"award-info":[{"award-number":["81973332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["KFJJ-2021-05"],"award-info":[{"award-number":["KFJJ-2021-05"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2308085MH311"],"award-info":[{"award-number":["2308085MH311"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bcp.2025.116930","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:46:14Z","timestamp":1744037174000},"page":"116930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A novel IgD-Fc\u03b4R blocker, IgD-Fc-Ig fusion protein, effectively alleviates abnormal activation of T cells the disease progression in systemic lupus erythematosus"],"prefix":"10.1016","volume":"237","author":[{"given":"Jingjing","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiemin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangxue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-0024","authenticated-orcid":false,"given":"Yujing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10441","key":"10.1016\/j.bcp.2025.116930_b0005","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2025.116930_b0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ard-2023-224854","article-title":"Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial","volume":"83","author":"Wu","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2025.116930_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073980","article-title":"Advances in the management of systemic lupus erythematosus","author":"Morand","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2025.116930_b0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2025.116930_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.bcp.2025.116930_b0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2025.116930_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic lupus erythematosus pathogenesis: interferon and beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116930_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030712","article-title":"New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond","volume":"9","author":"Demirkaya","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.116930_b0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10067-022-06457-9","article-title":"High serum immunoglobulin D levels in systemic lupus erythematosus: more to be found?","volume":"42","author":"Liang","year":"2023","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12967-022-03794-w","article-title":"A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death","volume":"20","author":"Rosato","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.116930_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105121","article-title":"A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19","volume":"148","author":"Macedo","year":"2022","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116930_b0070","first-page":"367","article-title":"Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations","volume":"31","author":"Brandtzaeg","year":"1978","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116930_b0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.it.2023.04.003","article-title":"Antibody-mediated regulation of basophils: emerging views and clinical implications","volume":"44","author":"Chen","year":"2023","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116930_b0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.immuni.2018.08.013","article-title":"Secreted IgD amplifies humoral T Helper 2 cell responses by binding basophils via galectin-9 and CD44","volume":"49","author":"Shan","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0085","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41467-022-28576-2","article-title":"Rad52 mediates class-switch DNA recombination to IgD","volume":"13","author":"Xu","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.alit.2022.09.004","article-title":"The dual aspects of IgD in the development of tolerance and the pathogenesis of allergic diseases","volume":"72","author":"Itoh","year":"2023","journal-title":"Allergol. Int."},{"key":"10.1016\/j.bcp.2025.116930_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114360","article-title":"The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis","volume":"183","author":"Wu","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116930_b0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","article-title":"IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-\u03baB signaling pathways","volume":"41","author":"Han","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.116930_b0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fimmu.2020.00755","article-title":"Regulation of T cell activities in rheumatoid arthritis by the novel fusion protein IgD-Fc-Ig","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08830185.2020.1861265","article-title":"The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D","volume":"41","author":"Nguyen","year":"2022","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41401-021-00665-w","article-title":"An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis","volume":"43","author":"Hu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1073\/pnas.85.2.559","article-title":"Exposure to crosslinked IgD induces receptors for IgD on T cells in vivo and in vitro","volume":"85","author":"Coico","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2025.116930_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109484","article-title":"IgD enhances the release of neutrophil extracellular traps (NETs) via Fc\u03b4R in rheumatoid arthritis patients","volume":"114","author":"Pan","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.116930_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106686","article-title":"IgD\/Fc\u03b4R is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein","volume":"189","author":"Wu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0135","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2025.116930_b0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fphar.2018.00004","article-title":"CP-25 attenuates the activation of CD4(+) T cells stimulated with immunoglobulin D in human","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116930_b0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.immuni.2016.04.011","article-title":"A cholesterol-based allostery model of T cell receptor phosphorylation","volume":"44","author":"Swamy","year":"2016","journal-title":"Immunity"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2025.116930_b0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2013.02.025","article-title":"Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA\/1 mice with collagen-induced arthritis","volume":"708","author":"Zhang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116930_b0155","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaci.2010.07.029","article-title":"Characterization of \u03b6-associated protein, 70 kd (ZAP70)\u2013deficient human lymphocytes","volume":"126","author":"Roifman","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaci.2014.06.025","article-title":"T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome","volume":"135","author":"Wu","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116930_b0165","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T Cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys1","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J. Immunol. (1950)"},{"issue":"8","key":"10.1016\/j.bcp.2025.116930_b0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.gene.6364252","article-title":"The R620W C\/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1","volume":"6","author":"Reddy","year":"2005","journal-title":"Genes Immun."},{"issue":"9","key":"10.1016\/j.bcp.2025.116930_b0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/ni.3231","article-title":"T cell receptor dwell times control the kinase activity of Zap70","volume":"16","author":"Klammt","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0180","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12885-015-1520-6","article-title":"Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation","volume":"15","author":"Vahedi","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00018-022-04657-9","article-title":"Cyclophilin A associates with and regulates the activity of ZAP70 in TCR\/CD3-stimulated T cells","volume":"80","author":"Anto","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"29","key":"10.1016\/j.bcp.2025.116930_b0190","doi-asserted-by":"crossref","first-page":"E5891","DOI":"10.1073\/pnas.1701990114","article-title":"Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bcp.2025.116930_b0195","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-020-0732-3","article-title":"Noncanonical binding of Lck to CD3\u03b5 promotes TCR signaling and CAR function","volume":"21","author":"Hartl","year":"2020","journal-title":"Nat. Immunol."},{"issue":"7775","key":"10.1016\/j.bcp.2025.116930_b0200","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41586-019-1537-0","article-title":"Structural basis of assembly of the human T cell receptor-CD3 complex","volume":"573","author":"Dong","year":"2019","journal-title":"Nature (London)"},{"key":"10.1016\/j.bcp.2025.116930_b0205","doi-asserted-by":"crossref","unstructured":"V.C. Kyttaris, Y. Wang, Y.T. Juang, A. Weinstein, G.C. Tsokos. Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus. J Immunol. 2007 (1);178(3):1960-1966.","DOI":"10.4049\/jimmunol.178.3.1960"},{"issue":"2","key":"10.1016\/j.bcp.2025.116930_b0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-019-04778-w","article-title":"JAK2 and PTPRC mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"39","author":"Qian","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116930_b0215","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.7150\/thno.82069","article-title":"Inhibition of Th17 cells by donepezil ameliorates experimental lung fibrosis and pulmonary hypertension","volume":"13","author":"Guo","year":"2023","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bcp.2025.116930_b0220","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1158\/1078-0432.CCR-20-4725","article-title":"Pacritinib combined with sirolimus and low-dose tacrolimus for GVHD prevention after allogeneic hematopoietic cell transplantation: preclinical and phase I trial results","volume":"27","author":"Pidala","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2025.116930_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152965","article-title":"Therapeutic effects of artesunate on lupus-prone MRL\/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2\u2013STAT3 signaling pathway","volume":"62","author":"Dang","year":"2019","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.bcp.2025.116930_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109602","article-title":"ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis","volume":"36","author":"Qian","year":"2021","journal-title":"Cell Rep."},{"issue":"10381","key":"10.1016\/j.bcp.2025.116930_b0235","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(22)02607-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)","volume":"401","author":"Morand","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0240","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"12","author":"Hasni","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.116930_b0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41392-023-01709-9","article-title":"Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.116930_b0250","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/aps.2015.76","article-title":"Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL\/MpSlac-lpr mice","volume":"36","author":"Yan","year":"2015","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:49:40Z","timestamp":1777380580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0006295225001923"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116930","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel IgD-Fc\u03b4R blocker, IgD-Fc-Ig fusion protein, effectively alleviates abnormal activation of T cells the disease progression in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116930"}}